{"public_id":"co_d858053bde10fbc6ffc65ef3215526d1","status":"active","merged_into_public_id":null,"resolved_public_id":"co_d858053bde10fbc6ffc65ef3215526d1","name":"A2A-adenosine receptor","description":"A pharmacologically distinct G-protein-coupled receptor subtype for adenosine expressed in the heart, studied here via cardiac-restricted transgenic overexpression.","aliases":["A2A-R"],"types":["receptor"],"contributors":[{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["extraction"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":30737109,"title":"Cardiac‐Restricted Overexpression of the A2A‐Adenosine Receptor in FVB Mice Transiently Increases Contractile Performance and Rescues the Heart Failure Phenotype in Mice Overexpressing the A1‐Adenosine Receptor","citation_count":23,"url":"https://sah.borca.ai/papers/30737109"}],"claims":[{"public_id":"cl_3b8c497f39e0a8c6bd6306ab54f6d740","text":"At 20 weeks, the positive effects of cardiac A2A-adenosine receptor overexpression on cardiac contractility diminished.","corpus_id":30737109,"url":"https://sah.borca.ai/claims/cl_3b8c497f39e0a8c6bd6306ab54f6d740"},{"public_id":"cl_98c8f3720625ee478ca81a29fcf43692","text":"Coexpression of high-level but not low-level A2A-adenosine receptor transgene enhanced survival, prevented left ventricular dysfunction and heart failure phenotype, and improved Ca2+ handling in mice overexpressing the A1-adenosine receptor.","corpus_id":30737109,"url":"https://sah.borca.ai/claims/cl_98c8f3720625ee478ca81a29fcf43692"},{"public_id":"cl_ac33f7b968f157047211e5d36e68a949","text":"Adenosine-mediated cardiac signaling requires a balance between A1-adenosine receptor and A2A-adenosine receptor activity.","corpus_id":30737109,"url":"https://sah.borca.ai/claims/cl_ac33f7b968f157047211e5d36e68a949"},{"public_id":"cl_d9e3a066ee07c958cab3b21dbb2fa881","text":"Mice with both low and high levels of cardiac A2A-adenosine receptor overexpression demonstrated increased cardiac contractility at 12 weeks, associated with higher systolic intracellular calcium concentration, higher maximal contraction amplitude, and enhanced sarcoplasmic reticulum Ca2+ uptake.","corpus_id":30737109,"url":"https://sah.borca.ai/claims/cl_d9e3a066ee07c958cab3b21dbb2fa881"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_d858053bde10fbc6ffc65ef3215526d1","url":"https://sah.borca.ai/concepts/co_d858053bde10fbc6ffc65ef3215526d1"}